Recruiting

Observational Study

Sponsor:

Université de Sherbrooke

Code:

NCT01698021

Conditions

Acute Coronary Syndrome

Myocardial Infarction

Unstable Angina

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The new assay of troponins T (highly sensitive troponins) detects concentrations much lower than before. Few data are currently available on their kinetics during acute coronary syndrome, especially in regard to the correlation with CK MB. The aim of the present study is to describe the kinetic of highly sensitive troponins in acute coronary syndrome, to correlate it with the concentration of CK MB, and possibly to evaluate their prognostic value with respect to infarct size .

Conditions

Acute Coronary Syndrome

Myocardial Infarction

Unstable Angina

Study ID

NCT01698021

Start date

Jun, 2013

Status verified date

Sep, 2012

Completion date

Nov, 2013

Anticipated

Primary completion date

Nov, 2013

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • >= 18 years-old
  • Clinical suspicion of an acute coronary syndrome; (will be analyzed only patients with aposteriori definitive diagnosis of unstable angina or myocardial infarction)

Exclusion Criteria:

  • none

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Evaluation of troponins kinetic in acute coronary syndromes. [ Time Frame: 72 hours ]

Central Contacts and Locations

Central contacts

Locations

Centre Hospitalier Universitaire de Sherbrooke, departement de cardiologie

Recruiting

Sherbrooke, Quebec, Canada, J1H 5N4

Contacts

Principal Investigator:

Paul Farand, MD MSc

More Information

Sponsor

Université de Sherbrooke

Last update posted

Jun 26, 2013

Last verified

Sep, 2012

Keywords

  • Creatine Kinase, MB form
  • Troponin
  • Acute coronary syndrome
  • myocardial infarction
  • Unstable angina

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Université de Sherbrooke on 2013-06-26.